Bratica Joseph 4
4 · Sarepta Therapeutics, Inc. · Filed Dec 14, 2020
Insider Transaction Report
Form 4
Bratica Joseph
Principal Financial Officer
Transactions
- Sale
Common Stock
2020-12-11$165.00/sh−1,115$183,975→ 8,140 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-11−1,115→ 12,285 totalExercise: $71.45From: 2019-03-05Exp: 2028-03-05→ Common Stock (1,115 underlying) - Exercise/Conversion
Common Stock
2020-12-11$71.45/sh+1,115$79,667→ 9,255 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.